AUA 2025: Impact of Timing of Recurrence on Survival Outcomes: Implications for Postoperative Management in a KEYNOTE-564 Population
AUA 2025 KEYNOTE-564 trial, clear cell renal cell carcinoma (ccRCC), adjuvant pembrolizumab, partial nephrectomy,
Related Articles
Maryland governor signs law to expand powers of the state’s prescription drug affordability board
Maryland Gov. Wes Moore signed a bill that will allow a state board to extend its mandate for lowering prescription drug costs to all residents,…
RFK Jr. declared war on chronic disease. First comes the battle over priorities
How would you solve the chronic disease epidemic? Here’s STAT’s extensive new data analysis, and nine ways to tackle the problem.
FDA Warns About Rare, Severe Itching After Stopping Cetirizine or Levocetirizine
The allergy medications of cetirizine or levocetirizine have led to pruritus in some patients who stopped using the medications after using them daily for a…
Health plans, advocacy groups descend on DC ahead of Medicaid markup hearing
It’s markup week in the House. | It’s markup week in the House for the ‘one big, beautiful bill.’ Lawmakers will debate significant programmatic changes…
Health plans, advocacy groups descend on DC ahead of Medicaid markup hearing
It’s markup week in the House. | It’s markup week in the House for the ‘one big, beautiful bill.’ Lawmakers will debate significant programmatic changes…
Rademikibart Improves Lung Function in Patients with Asthma within 24 Hours
This analysis highlights the rapid improvements seen in patients with uncontrolled asthma within 24 hours of their initial rademikibart dose.
Governors Address Behavioral Health Needs for 2025
Across the country, governors continue to make behavioral health a priority—using their State of the State, budget, and inaugural addresses to highlight investments in behavioral…
Access to diabetes care in lower-income countries still lags for children, despite pharma efforts
Access to diabetes care in lower-income countries still lags for children, despite efforts from insulin makers.
Scribe
Welcome to Scribe, your new assistant for clinical note-taking! This HIPAA compliant AI-powered tool listens to your patient visits and creates an EHR-ready summary. Say…
The companies pushing MRI scans and blood tests for longevity
Longevity startups have become trendy in digital health, drawing attention from celebrity and established investors.
